Surgical intervention for severe post-RYGB hypoglycemia includes pancreatic resection, RYGB reversal, and gastric pouch restriction, with resolution of symptoms in 67%, 76%, and 82% of patients, ...
Reports of fluoroquinolone-induced hypoglycemia are abundant, but reports of hyperglycemia induced by fluoroquinolones are also available. [15–19] The primary theory of fluoroquinolone ...
Piper Sandler lowered shares of Xeris Biopharma (NASDAQ:XERS – Free Report) from an overweight rating to a neutral rating in a research report report published on Monday morning, Marketbeat.com ...
MBX Biosciences (NASDAQ:MBX) is a recent IPO that develops precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead asset is MBX 2109, a once-weekly PTH Replacement ...